Anti-hydroxylase antibodies and uses thereof
Antibodies, or antigen-binding portions thereof, to aspartyl (asparaginyl) β-hydroxylase are provided. The anti-aspartyl (asparaginyl) β-hydroxylase antibodies, or antigen-binding portions thereof, can modulate activity of aspartyl (asparaginyl) β-hydroxylase.
1. An isolated human antibody or a fragment thereof, which comprises at least three complementarity determining regions (CDRs), wherein one of the at least three CDRs has the sequence of SEQ ID NO:51 and which antibody or fragment thereof specifically binds to an aspartyl (asparaginyl) β-hydroxylase (AAH).
2. The antibody of claim 1 , which is a single chain antibody (scFv).
3. The antibody or fragment of claim 1 , which specifically binds to a catalytic domain of the AAH.
4. The antibody or fragment of claim 1 , which has an affinity for AAH equal to or less than about 1 μM.
5. The antibody or fragment of claim 1 , which comprises a light chain variable region selected from any of SEQ ID NOs. 2, 20, 24, 26, 30, 120, 122, 124, 126, 128, 130, 132, 134, 136, 138, 140, 142, 144, 146, 148, 269, or 271.
6. The antibody or fragment of claim 1 , which effectively competes with clone 11 for binding to an epitope bound by clone 11.
7. The antibody of claim 2 , wherein the scFv comprises an amino acid sequence selected from any of SEQ ID NOs. 2, 20, 24, 26, 30, 120, 122, 124, 126, 128, 130, 132, 134, 136, 138, 140, 142, 144, 146, 148, 269, 271, 31, 40, 42, 43, 45, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 279, or 280.
8. The antibody or fragment of claim 1 , which is in a composition comprising a physiologically acceptable diluent.
9. The antibody or fragment of claim 1 , which further comprises a label or a toxin.
10. The antibody or fragment of claim 1 , wherein the CDR having SEQ ID NO:51 is within a variable light chain region (VL).
11. The antibody or fragment of claim 1 , wherein the other two CDRs of the at least three CDRs have the sequences of SEQ ID NO:49 and SEQ ID NO:50.
12. The antibody or fragment of claim 1 , which further comprises a CDR having the sequence of SEQ ID NO:46.
13. The antibody or fragment of claim 1 , which further comprises a CDR having the sequence of SEQ ID NO:47 or SEQ ID NO:48.
14. The antibody of claim 2 , which has the amino acid sequence of SEQ ID NO:31.
15. The antibody of claim 2 , which has the amino acid sequence of SEQ ID NO: 20.
16. An isolated human antibody, which comprises at least three complementary determining regions (CDRs), one of which has the sequence of SEQ ID NO:51, and which antibody specifically binds to human aspartyl (asparaginyl) β-hydroxylase (HAAH).